Simultaneous Estimation of Atenolol and Nifedipine to be incorporated in Buccal Patch: Method Development and Validation by UV-Spectrophotometric Approach
DOI:
https://doi.org/10.12300/rrjopc.v2i1.412Abstract
A simple, precise, accurate and reproducible spectrophotometric method has been developed for the simultaneous estimation of Atenolol and Nifedipine. Atenolol and Nifedipine are used in combined dosage form for cardiovascular diseases. Hence, it is necessary to develop a method to analyze the two drugs simultaneously by UV-spectroscopic method. Simulated salivary fluid of pH 6.8 was used as the medium. Simultaneous equation method was developed as per ICH guidelines. The absorption maxima of two drugs were found to be 274 and 238 nm for Atenolol and Nifedipine respectively. Different analytical parameters such as linearity, precision, and accuracy, limit of detection (LOD) and limit of quantitation (LOQ) were determined as per ICH guidelines. Atenolol and Nifedipine obeyed Beer’s law in the concentration range of 50–300 μg/mL and 3–18 μg/mL respectively. The correlation coefficient of these drugs was found to be close to 1.00, indicating good linearity. The % RSD (percent relative standard deviation) was found to be less than 2% as required by ICH guidelines, which indicates the validity of method. The proposed method is recommended for routine analysis since it is rapid, reliable, reproducible, sensitive, economic, selective and specific.
Keywords: Simultaneous estimation, UV spectrophotometer, Atenolol and Nifedipine
Cite this Article
Kudtarkar Sanjivi, Patil Amit B, Narayana Charyulu R, et al. Simultaneous estimation of Atenolol and Nifedipine to be incorporated in buccal patch: Method development and validation by UV-spectrophotometric approach. Research & Reviews: A Journal of Pharmacognosy. 2015; 2(1): 28–32p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |